EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lipids and Lipid‐Lowering Drugs With Risk of Intervertebral Disc Degeneration: A Mendelian Randomization Study

Aochen Xu iD, Jiabin Yuan

Genetics Research · 2026-01 · 2026 (1)

DOI: 10.1155/genr/5378960 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetics Research, online erschienen am 29.07.2026. Verfasst von Aochen Xu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Spine Surgery, Ningbo No. 6 Hospital, 1059 East Zhongshan Road, Ningbo Zhejiang, 315000, China, nbdlyy.com. Hauptthemen laut MEDLINE: Intervertebral Disc Degeneration, Lipids, Hypolipidemic Agents. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study examined whether circulating lipid traits and lipid‐lowering drug targets are causally associated with intervertebral disc degeneration (IVDD) using a Mendelian randomization (MR) framework. We analyzed summary‐level data from genome‐wide association studies (GWASs) covering apolipoproteins, lipid parameters, and IVDD. Univariable analysis revealed that inherently elevated high‐density lipoprotein cholesterol (HDL‐C) correlated with reduced IVDD susceptibility. By contrast, low‐density lipoprotein cholesterol (LDL‐C), triglycerides (TGs), apolipoprotein A‐I (Apoa‐I), and apolipoprotein B (Apob) did not remain significant after Bonferroni correction. Upon adjusting for body mass index (BMI) in a multivariable framework, the protective link between HDL‐C and IVDD held strong, whereas LDL‐C, TG, and Apob remained nonsignificant. Summary data–based MR and drug–target MR analyses further suggested a significant association between NPC1L1 gene expression and IVDD susceptibility. Overall, these results highlight the potential involvement of lipid pathways in disc degeneration and justify further biological and clinical investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intervertebral Disc DegenerationLipidsHypolipidemic AgentsHumansMendelian Randomization AnalysisGenome-Wide Association StudyGenetic Predisposition to DiseaseApolipoprotein A-IApolipoproteins BTriglyceridesPolymorphism, Single NucleotideCholesterol, HDLCholesterol, LDL

Substanzen

LipidsHypolipidemic AgentsApolipoprotein A-IApolipoproteins BTriglyceridesCholesterol, HDLCholesterol, LDL

Autor:innen und Institutionen

  • Department of Spine Surgery, Ningbo No. 6 Hospital, 1059 East Zhongshan Road, Ningbo Zhejiang, 315000, China, nbdlyy.com.
  • Department of Spine Surgery, Changhai Hospital, Navy Military Medical University, 168 Changhai Road, Shanghai 200433, China, chhospital.com.cn.

ORCID-Profile: Aochen Xu

Zitieren

APA

Xu, A., & Yuan, J. (2026). Lipids and Lipid‐Lowering Drugs With Risk of Intervertebral Disc Degeneration: A Mendelian Randomization Study. Genetics Research, 2026(1). https://doi.org/10.1155/genr/5378960

Vancouver

Xu A, Yuan J. Lipids and Lipid‐Lowering Drugs With Risk of Intervertebral Disc Degeneration: A Mendelian Randomization Study. Genetics Research. 2026;2026(1). doi:10.1155/genr/5378960

BibTeX
@article{Xu2026,
  author = {Xu, Aochen and Yuan, Jiabin},
  title = {Lipids and Lipid‐Lowering Drugs With Risk of Intervertebral Disc Degeneration: A Mendelian Randomization Study},
  journal = {Genetics Research},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/genr/5378960}
}
Kostenlos starten →